| scholarly article | Q13442814 |
| P50 | author | Mel Krajden | Q6810759 |
| Danuta M. Skowronski | Q111259505 | ||
| Suzana Sabaiduc | Q114718265 | ||
| Anne-Luise Winter | Q114718267 | ||
| James A Dickinson | Q42422634 | ||
| Catharine Chambers | Q57259188 | ||
| Yan Li | Q69032212 | ||
| Nathalie Bastien | Q69032280 | ||
| Hugues Charest | Q86870110 | ||
| Gaston De Serres | Q86870133 | ||
| Jonathan B Gubbay | Q87716515 | ||
| Steven J Drews | Q90185362 | ||
| Christine Martineau | Q107855435 | ||
| P2860 | cites work | Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance | Q28728106 |
| Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. | Q30360290 | ||
| Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines. | Q30363279 | ||
| Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada. | Q30364076 | ||
| Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated | Q30381731 | ||
| Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. | Q30383312 | ||
| Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting | Q30395224 | ||
| Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains | Q30396097 | ||
| Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands | Q30398281 | ||
| Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. | Q30399272 | ||
| Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. | Q30399334 | ||
| Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study | Q30414952 | ||
| Serologic assays for influenza surveillance, diagnosis and vaccine evaluation | Q34194336 | ||
| Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories | Q34332806 | ||
| Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season | Q34480810 | ||
| Antibody landscapes after influenza virus infection or vaccination. | Q34580640 | ||
| Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis | Q34783486 | ||
| The wages of original antigenic sin. | Q34908157 | ||
| Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses | Q35130915 | ||
| Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type | Q35531934 | ||
| Focused antibody response to influenza linked to antigenic drift | Q36184767 | ||
| Variable efficacy of repeated annual influenza vaccination | Q36705674 | ||
| Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. | Q37355265 | ||
| Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season | Q38415770 | ||
| Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
| Immune history and influenza virus susceptibility | Q39088963 | ||
| Repeated annual influenza vaccination and vaccine effectiveness: review of evidence | Q39340731 | ||
| Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. | Q39884414 | ||
| Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season | Q40089214 | ||
| Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2). | Q40120056 | ||
| The Doctrine of Original Antigenic Sin: Separating Good From Evil | Q40248207 | ||
| The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). | Q41263011 | ||
| Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season | Q41510283 | ||
| Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada | Q41932798 | ||
| Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. | Q42237299 | ||
| Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine | Q42242172 | ||
| Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/Yamagata | Q42613649 | ||
| Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs | Q44077186 | ||
| A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season | Q47843797 | ||
| Estimates of deaths associated with seasonal influenza --- United States, 1976-2007 | Q50131053 | ||
| Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study. | Q50894561 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Canada | Q16 |
| influenza vaccine | Q383260 | ||
| P304 | page(s) | 1487-1500 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada | |
| P478 | volume | 216 |
| Q47583920 | 2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children. |
| Q92706811 | A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy) |
| Q41932798 | Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada |
| Q50065275 | Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness |
| Q64054477 | Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic |
| Q98889330 | Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263) |
| Q49204982 | Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018. |
| Q92437425 | Effectiveness of the quadrivalent inactivated influenza vaccine in Japan during the 2015-2016 season: A test-negative case-control study comparing the results by real time PCR, virus isolation |
| Q58722425 | Estimating Vaccine-Driven Selection in Seasonal Influenza |
| Q91636311 | Heterogeneity of Circulating Influenza Viruses and Their Impact on Influenza Virus Vaccine Effectiveness During the Influenza Seasons 2016/17 to 2018/19 in Austria |
| Q92482109 | Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs |
| Q59349308 | Immune History and Influenza Vaccine Effectiveness |
| Q47549841 | Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States |
| Q64055452 | Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network |
| Q89600520 | Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019 |
| Q87852509 | Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18 |
| Q61810206 | Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019 |
| Q89881062 | Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020 |
| Q64126022 | Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment |
| Q57093836 | Investigating the Legacy of 1918 Pandemic on Age-Related Sero-Epidemiology and Immune Responses to Subsequent Influenza A(H1N1) Viruses Through a Structural Equation Model |
| Q64116962 | Novel Approaches for The Development of Live Attenuated Influenza Vaccines |
| Q57093953 | Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity |
| Q91941703 | Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets |
| Q64074349 | Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses |
| Q57100141 | Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness? |
| Q59357667 | The Effects of Birth Year, Age and Sex on Hemagglutination Inhibition Antibody Responses to Influenza Vaccination |
| Q57094348 | The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine |
| Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Search more.